163 related articles for article (PubMed ID: 36517838)
1. Higher circulating Trimethylamine N-oxide levels are associated with worse severity and prognosis in pulmonary hypertension: a cohort study.
Yang Y; Yang B; Li X; Xue L; Liu B; Liang Y; Zhao Z; Luo Q; Liu Z; Zeng Q; Xiong C
Respir Res; 2022 Dec; 23(1):344. PubMed ID: 36517838
[TBL] [Abstract][Full Text] [Related]
2. The significance of dynamic monitoring plasma TMAO level in pulmonary arterial hypertension - a cohort study.
Yang Y; Li X; Wang P; Shu S; Liu B; Liang Y; Yang B; Zhao Z; Luo Q; Liu Z; Zheng L; Zeng Q; Xiong C
Ther Adv Respir Dis; 2024; 18():17534666231224692. PubMed ID: 38205629
[TBL] [Abstract][Full Text] [Related]
3. Circulating choline levels are associated with prognoses in patients with pulmonary hypertension: a cohort study.
Yang Y; Yang B; Liu B; Liang Y; Luo Q; Zhao Z; Liu Z; Zeng Q; Xiong C
BMC Pulm Med; 2023 Sep; 23(1):313. PubMed ID: 37689632
[TBL] [Abstract][Full Text] [Related]
4. High-circulating gut microbiota-dependent metabolite trimethylamine N-oxide is associated with poor prognosis in pulmonary arterial hypertension.
Yang Y; Zeng Q; Gao J; Yang B; Zhou J; Li K; Li L; Wang A; Li X; Liu Z; Luo Q; Zhao Z; Liu B; Xue J; Jiang X; Konerman MC; Zheng L; Xiong C
Eur Heart J Open; 2022 Sep; 2(5):oeac021. PubMed ID: 36071697
[TBL] [Abstract][Full Text] [Related]
5. Trimethylamine N-oxide and prognosis in acute heart failure.
Suzuki T; Heaney LM; Bhandari SS; Jones DJ; Ng LL
Heart; 2016 Jun; 102(11):841-8. PubMed ID: 26869641
[TBL] [Abstract][Full Text] [Related]
6. Circulating acetylcholine serves as a potential biomarker role in pulmonary hypertension.
Yang Y; Xu J; Shu S; Wang P; Liang Y; Liu B; Yang B; Zhang H; Zhao Q; Zhao Z; Luo Q; Liu Z; Zeng Q; Xiong C
BMC Pulm Med; 2024 Jan; 24(1):35. PubMed ID: 38229103
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
8. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbial Metabolite Trimethylamine
Huang Y; Lin F; Tang R; Bao C; Zhou Q; Ye K; Shen Y; Liu C; Hong C; Yang K; Tang H; Wang J; Lu W; Wang T
Am J Respir Cell Mol Biol; 2022 Apr; 66(4):452-460. PubMed ID: 35100519
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
11. [The prediction value of combined serum levels of TMAO and TML for poor prognosis in patients with heart failure].
Xi R; Fan Q; Tao R
Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Apr; 52(4):405-412. PubMed ID: 38644256
[No Abstract] [Full Text] [Related]
12. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
[TBL] [Abstract][Full Text] [Related]
14. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.
Senthong V; Wang Z; Li XS; Fan Y; Wu Y; Tang WH; Hazen SL
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287696
[TBL] [Abstract][Full Text] [Related]
15. Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction.
Suzuki T; Heaney LM; Jones DJ; Ng LL
Clin Chem; 2017 Jan; 63(1):420-428. PubMed ID: 28062632
[TBL] [Abstract][Full Text] [Related]
16. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
17. Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension.
Richter MJ; Tiede SL; Sommer N; Schmidt T; Seeger W; Ghofrani HA; Schermuly R; Gall H
PLoS One; 2016; 11(11):e0165982. PubMed ID: 27802345
[TBL] [Abstract][Full Text] [Related]
18. Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: A meta-analysis and dose-response relationship analysis.
Han JM; Guo L; Chen XH; Xie Q; Song XY; Ma YL
Medicine (Baltimore); 2024 Jan; 103(1):e36784. PubMed ID: 38181288
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Plasma Trimethylamine N-Oxide Levels and Renal Dysfunction in Patients with Hypertension.
Zhou J; Wang D; Li B; Li X; Lai X; Lei S; Li N; Zhang X
Kidney Blood Press Res; 2021; 46(4):421-432. PubMed ID: 34233325
[TBL] [Abstract][Full Text] [Related]
20. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.
Kanitsoraphan C; Rattanawong P; Charoensri S; Senthong V
Curr Nutr Rep; 2018 Dec; 7(4):207-213. PubMed ID: 30362023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
